Construction of retroviral vectors with enhanced efficiency of transgene expression

Journal of Virological Methods
Sung Ho HahmKwan Hee Lee

Abstract

Retroviral vectors have been widely used in gene therapy due to their simple genomic structure and high transduction efficiency. We report a construction of Moloney murine sarcoma virus (MoMSV) and Moloney murine leukemia virus (MoMLV) hybrid-based retroviral vectors with significantly improved efficiency of transgene expression after stable incorporation into the host genome. In these vectors, the residual gag gene coding sequence located in the extended region of packaging signal was removed. These vectors, therefore, contain no coding sequence for the gag, pol, or env gene that can be used for homologous recombination with sequences introduced in the packaging system for a recombinant competent retrovirus (RCR) generation. A strong splice acceptor site obtained from the exon/intron junction of either the chimpanzee EF1-alpha gene or the human CMV major immediate early gene was placed downstream of the MoMSV packaging signal (Psi), significantly improving the efficiency of transgene expression. The 5' LTR U3 sequence was replaced with an extended human CMV major immediate early gene enhancer/promoter for a strong expression of full-length messages from the viral backbone, helping to maintain high levels of viral titer. These ...Continue Reading

References

Jan 1, 1990·Human Gene Therapy·A D Miller
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·O Danos, R C Mulligan
Apr 1, 1994·American Journal of Respiratory Cell and Molecular Biology·J P MetcalfG W Hunninghake
Feb 21, 1998·Trends in Biotechnology·P D RobbinsS C Ghivizzani
Nov 6, 1998·Pharmacology & Therapeutics·P D Robbins, S C Ghivizzani
May 18, 2000·Reviews in Medical Virology·G PalùM Pizzato
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D W EmeryG Stamatoyannopoulos
Nov 10, 2001·Annual Review of Genomics and Human Genetics·A Pfeifer, I M Verma
Aug 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bonnie Burgess-BeusseGary Felsenfeld
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Nov 1, 2002·Cell·Mariano Labrador, Victor G Corces
Nov 1, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Frederic Bushman
Jan 4, 2003·Blood·Christopher BaumChristof von Kalle
Jan 17, 2003·The New England Journal of Medicine·Salima Hacein-Bey-AbinaAlain Fischer
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Suzanne Sandmeyer
Jun 14, 2003·Science·Didier Trono
Jul 2, 2003·Nature Reviews. Cancer·Donald B KohnJoseph C Glorioso

❮ Previous
Next ❯

Citations

Oct 20, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wenqin XuMaribeth V Eiden
May 6, 2006·Biochemical and Biophysical Research Communications·H KhanahmadS Zeinali
Oct 8, 2009·Alternatives to Laboratory Animals : ATLA·Jarrod Bailey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.